Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment

Pulmonary Fibrosis

SILDENAFIL IMPROVES VASCULAR ENDOTHELIAL FUNCTION IN PATIENTS WITH CYSTIC FIBROSIS

Am J Physiol Heart Circ Physiol.

Rodriguez Miguelez P, Seigler N, Tucker MA, Csanyi G, McKie KT, Forseen C, Harris RA

doi: 10.1152/ajpheart.00301.2018.

Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study

Infection.

Deppisch C, Herrmann G, Graepler-Mainka U, Wirtz H, Heyder S, Engel C, Marschal M, Miller CC, Riethmüller J

doi: 10.1007/s15010-016-0879-x.

RECOMMENDED

Pulmonary Fibrosis

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L

doi: 10.1016/j.jcf.2020.07.022.

RECOMMENDED

Pulmonary Fibrosis

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Cyst Fibros

Nicholson TT, Smith A, McKone EF, Gallagher CG

doi: 10.1016/j.jcf.2021.08.017

COPD

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Respir Res.

Csoma B, Bikov A, Nagy L, Tóth B, Tábi T, Szűcs G, Komlósi ZI, Müller V, Losonczy G, Lázár Z

doi: 10.1186/s12931-019-1133-8.

Pulmonary Fibrosis

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

Pediatr Pulmonol.

Bruch BA, Singh SB, Ramsey LJ, Starner TD

doi: 10.1002/ppul.24024.

Pulmonary Fibrosis

Effects of Lumacaftor/Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis

Am J Respir Crit Care Med.

Graeber SY, Dopfer C, Naehrlich L, Gyulumyan L, Scheuermann H, Hirtz S, Wege S, Mairbäurl H, Dorda M, Hyde R, Bagheri-Hanson A, Rueckes-Nilges C, Fischer S, Mall MA, Tümmler B

doi: 10.1164/

Pulmonary Fibrosis

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Chest.

Hong LT, Liou TG, Deka R, King JB, Stevens V, Young DC

doi: 10.1016/j.chest.2018.06.002.

RECOMMENDED

Pulmonary Fibrosis

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Cochrane Database Syst Rev.

Smith S, Rowbotham NJ, Charbek E

doi: 10.1002/14651858.

Related content

SILDENAFIL IMPROVES VASCULAR ENDOTHELIAL FUNCTION IN PATIENTS WITH CYSTIC FIBROSIS

Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study

The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

Effects of Lumacaftor/Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis